{"slug":"ss-31-nerve-damage","verification":{"valid":true,"entries":2,"head":"35fe3bc5e25b14dea3632685e649847b14b6bbf3338a6945cba40bb3c4041881"},"energy":{"passes":2,"tokens_in":40070,"tokens_out":3247,"tokens_total":43317,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"35fe3bc5e25b14dea3632685e649847b14b6bbf3338a6945cba40bb3c4041881"},"provenance":[{"ts":"2026-06-29T23:51:01.974Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Ss 31 for Nerve Damage\nSlug: ss-31-nerve-damage\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\",\"section_title\":\"Why SS-31 (Elamipretide) might help you\",\"layer\":\"mitochondrial\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **SS-31 (Elamipretide)** → mitochondrial\",\"section_headings\":[\"What's breaking down\",\"Why SS-31 (Elamipretide) might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do ","response":"{\n  \"slug\": \"ss-31-nerve-damage\",\n  \"title\": \"SS-31 (Elamipretide) for Nerve Damage: Mitochondrial Repair Pathways\",\n  \"body\": \"## What's breaking down\\nNerve damage often starts with trauma, compression, inflammation, or metabolic stress that hits mitochondria first. Mitochondria supply ATP to axons and support structures. When they falter, reactive oxygen species rise, cardiolipin in the inner membrane oxidizes, and the permeability transition pore opens. This triggers apoptosis signals, swelling, and loss of neuronal integrity. Secondary cascades then expand the lesion: glial scarring forms, synaptic connections drop, and functional recovery stalls. In spinal cord injury models, contusion causes immediate mechanical disruption followed by mitochondrial collapse in surviving neurons. Similar patterns appear in optic nerve injury, traumatic brain injury, and inflammatory states that model aspects of neuropathy. The core issue is repair lagging behind ongoing degeneration at the mitochondrial layer.\\n\\n## Why SS-31 (Elamipretide) might help you\\nSS-31 targets the inner mitochondrial membrane and binds cardiolipin. If mitochondrial dysfunction drives part of your nerve damage, this binding stabilizes the membrane, reduces electron leakage, and curbs ROS production. Step one: preserved cardiolipin keeps the electron transport chain efficient, so ATP output holds up instead of crashing. Step two: lower ROS means less oxidation of cardiolipin and fewer triggers for the permeability transition pore. Step three: with apoptosis signals damped (lower cleaved caspase-3 and Bax, higher Bcl-2 in early phases), more neurons survive the acute window. Step four: over weeks, this preservation links to less lesion expansion, reduced astrogliosis, and markers of axonal and synaptic remodeling in chronic stages. Therefore for you: if mitochondrial stress sits inside your nerve damage picture, SS-31 is discussed because it acts on tissue-level repair pathways rather than masking sympt","tokens_in":40070,"tokens_out":3247,"cost":0,"prev":"genesis","hash":"0232cdbc259bb01ad50212bc89e31b8672aec3c3262f8c46849e15141b3fe862"},{"ts":"2026-07-17T02:42:06.160Z","model":"owner","action":"voxel_divide","prompt":"","input":"ss-31-nerve-damage","response":"18 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"0232cdbc259bb01ad50212bc89e31b8672aec3c3262f8c46849e15141b3fe862","hash":"35fe3bc5e25b14dea3632685e649847b14b6bbf3338a6945cba40bb3c4041881"}]}